Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/4A3 stock hub

FRA/4A3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4A3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/4A3FRA/4A3

—

Loading chart…

In the news

Latest news · FRA/4A3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-37.1

P25 n/aP50 n/aP75 n/a

ROIC-1,116

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4A3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

156

Groups with data

Currency

EUR

Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	650
Employees Change	29%
Employees Change Percent	4.25
Enterprise value	EUR 842.8M
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.3B
Price	EUR 9.38
Price currency	EUR
Rev Per Employee	74,255.38x
Sic	2836
Symbol	fra/4A3
Website	https://www.immatics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.17%
EV Earnings	-4.29x
EV/FCF	-4.6x
EV/Sales	17.5x
FCF yield	-14.14%
P/B ratio	2.68x
P/S ratio	26.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-280.87%
Gross Profit	EUR -135.6M
Net Income	EUR -196.4M
Pretax Margin	-411.13%
Profit Per Employee	EUR -302,226
ROA	-18.08
Roa5y	-10.93
ROCE	-35.05
ROE	-37.1
Roe5y	-44.27
ROIC	-1,116

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	134.63%
Cagr3y	2.52%
Revenue Growth	-69.03x
Revenue Growth Q	-64.87x
Revenue Growth3 Y	-34.64x
Revenue Growth5 Y	9.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.08
Assets	EUR 562.3M
Cash	EUR 469.3M
Current Assets	EUR 504M
Current Liabilities	EUR 43M
Debt	EUR 15.6M
Debt Equity	EUR 0.03
Debt FCF	EUR -0.09
Equity	EUR 484.1M
Interest Coverage	-192.4
Liabilities	EUR 78.2M
Long Term Assets	EUR 58.3M
Long Term Liabilities	EUR 35.2M
Net Cash	EUR 453.7M
Net Cash By Market Cap	EUR 35.02
Net Cash Growth	-22.87%
Net Debt Equity	EUR -0.94
Tangible Book Value	EUR 482.5M
Tangible Book Value Per Share	EUR 3.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.72
Net Working Capital	EUR -5.6M
Quick ratio	11.07
Working Capital	EUR 461M
Working Capital Turnover	EUR 0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	134.49%
200-day SMA	7.77
3Y total return	7.76%
50-day SMA	8.8
50-day SMA vs 200-day SMA	50over200
All Time High	13.48
All Time High Change	-30.45%
All Time High Date	2023-09-11
All Time Low	3.08
All Time Low Change	203.99%
All Time Low Date	2025-04-07
ATR	0.23
Ch YTD	10.23
High	9.38
High52	10.07
High52 Date	2025-12-05
High52ch	-6.9%
Low	9.38
Low52	3.81
Low52 Date	2025-05-09
Low52ch	145.93%
Ma50ch	6.55%
Price vs 200-day SMA	20.73%
RSI	53.33
RSI Monthly	55.87
RSI Weekly	60.6
Sharpe ratio	1.57x
Sortino ratio	2.69
Total Return	-14.56%
Tr YTD	10.23
Tr1m	6.05%
Tr1w	3.59%
Tr3m	27.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -182M
Operating margin	-377.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,268,425%
Net Borrowing	-2,959,000
Shares Insiders	3.51%
Shares Institutions	45.93%
Shares Qo Q	2.6%
Shares Yo Y	14.56%
Short Ratio	11.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -198.2M
Average Volume	203.3x
Bv Per Share	3.61
CAPEX	EUR -6.6M
Ch1m	6.05
Ch1w	3.59
Ch1y	134.5
Ch3m	27.12
Ch3y	7.76
Ch6m	15.6
Change	-2.9%
Change From Open	-0.05
Close	9.66
Days Gap	-2.9
Depreciation Amortization	9,141,000
Earnings Date	2026-05-13
EBIT	EUR -182M
EBITDA	EUR -172.9M
EPS	EUR -1.61
F Score	2
FCF	EUR -183.2M
FCF EV Yield	-21.74x
Financing CF	97,353,000
Fiscal Year End	December
Income Tax	EUR -2M
Investing CF	204,787,000
Is Primary Listing	0
Last Earnings Date	2025-11-21
Last Report Date	2025-12-31
Ma150	8.59
Ma150ch	9.09%
Ma20	9.36
Ma20ch	0.2%
Net CF	109,170,000
Next Earnings Date	2026-05-13
Open	9.38
Ppne	54,897,000
Price Date	2026-05-08
Ptbv Ratio	2.68
Relative Volume	0.25x
Revenue	48,266,000x
SBC By Revenue	31.11x
Share Based Comp	15,015,000
Tax By Revenue	-4.12x
Tr6m	15.6%
Volume	0
Z Score	3.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/4A3 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/4A3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4A3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+45.9%

Share of float held by funds and institutions

Insider ownership

+3.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/4A3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.3

Neutral momentum band

Price vs 200-day MA

+20.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4A3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4A3 stock rating?

fra/4A3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4A3 analysis?

The full report lives at /stocks/fra/4A3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4A3?

The latest report frames fra/4A3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4A3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.